Limba
|
PLX8394 is a next-generation, orally available, small-molecule BRAFinhibitor with IC50 values of 3.8 nM, 14 nM and 23 nM for BRAF(V600E), WT BRAF and CRAF respectively. It has potential antineoplastic activity.
Price | 1.262,00 RON (preturile sunt fara TVA) |
---|---|
Description |
PLX8394 is a next-generation, orally available, small-molecule BRAFinhibitor with IC50 values of 3.8 nM, 14 nM and 23 nM for BRAF(V600E), WT BRAF and CRAF respectively. It has potential antineoplastic activity. |